Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-05), Frontage Holdings's 3-1 Month Momentum % is 36.36%.
The industry rank for Frontage Holdings's 3-1 Month Momentum % or its related term are showing as below:
FGHQF's 3-1 Month Momentum % is ranked better than 95.1% of 1387
companies
in the Biotechnology industry
Industry Median: -5.77
vs FGHQF: 36.36
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Frontage Holdings 3-1 Month Momentum % Related Terms
FGHQF vs VRTX, REGN, MRNA: 3-1 Month Momentum % Comparison
For the Biotechnology subindustry, Frontage Holdings's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frontage Holdings 3-1 Month Momentum % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Frontage Holdings's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Frontage Holdings's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Frontage Holdings (FGHQF) has a 3-1 Month Momentum % of 36.36% as of Sep. 05, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Frontage Holdings and its competitors. According to the industry distribution chart, Frontage Holdings ranks #68 out of 1387 companies in the Biotechnology industry, placing it in the top 4.9%.
Is Frontage Holdings' 3-1 Month Momentum % too high?
Frontage Holdings' current 3-1 Month Momentum % is 36.36%. Based on the distribution chart, Frontage Holdings ranks #68 out of 1387 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Frontage Holdings has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Frontage Holdings' 3-1 Month Momentum % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Frontage Holdings ranks #68 out of 1387 companies for 3-1 Month Momentum %. This places Frontage Holdings in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Biotechnology company?
A good 3-1 Month Momentum % depends on the Biotechnology industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Frontage Holdings and its competitors. Frontage Holdings's current 3-1 Month Momentum % is 36.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frontage Holdings stock overvalued right now?
Based on GuruFocus' analysis, Frontage Holdings (FGHQF) is currently considered Fairly Valued. The stock's GF Value™ is $0.18, compared to a current price of $0.18 — trading 2.8% below its estimated fair value. The current 3-1 Month Momentum % is 36.36%. Frontage Holdings' overall GF Score™ is 68/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Frontage Holdings (FGHQF), the current 3-1 Month Momentum % is 36.36% as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Frontage Holdings (FGHQF) Overvalued in 2026?
Based on GuruFocus' analysis, Frontage Holdings stock appears to be undervalued.
The current stock price of $0.18 is trading 2.8% below its estimated GF Value™ of $0.18.
GuruFocus considers Frontage Holdings to be Fairly Valued.
Key valuation signals for FGHQF:
3-1 Month Momentum %: 36.36%
GF Value™: $0.18 vs. price of $0.18 (2.8% below fair value)
No single metric tells the full story. See the FGHQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Frontage Holdings Corp provides laboratory and related services to pharmaceutical and agrochemical companies. Its segments include North America and Europe segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the USA, Canada and Europe; and PRC segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the PRC. It derives majority of the revenue from North America and Europe segment. Geographically majority of the revenue is derived from USA and Canada.
68GF Score
Get the complete analysis for FGHQF
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FGHQF has been successfully added to your 
